ScopusElsevier Scopus
Status
Active
Coverage
2010–present
Source type
Journal
Open access
Yes
CiteScore
5.3
SJR · SCImago
1.018
Q1 SJR quartile
H-index
41
Best quartile
Q1 · 76th pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 36 / 151 | 76th | Q1 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Therapeutic Advances in Hematology
Therapeutic Advances in Hematology is Scopus-indexed (Q1, CiteScore 5.3), WoS SCIE, DOAJ. Published by SAGE Publications Inc..
Checked against the index lists dated .
ISSN 2040-6207Verify ISSN ↗2040-6215Verify ISSN ↗
Publisher: SAGE Publications Inc.
Scopus · Q1WoS · SCIEOpen Access
5.3
CiteScore 2025
Q1
Best quartile
3
Indexed in
Cost to publish: Checking DOAJ for article charges…
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
DOAJDirectory of Open Access Journals (live)
Listed in DOAJ
Open accessFully open access, peer reviewed
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Therapeutic Advances in Hematology indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q1, CiteScore 5.3.
What quartile is Therapeutic Advances in Hematology in Scopus?
Therapeutic Advances in Hematology is Q1 in Hematology (rank 36 of 151), by CiteScore 2025.
What is the impact factor of Therapeutic Advances in Hematology?
Therapeutic Advances in Hematology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.3, which places it in quartile Q1 at the 76th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.018, quartile Q1, with an H-index of 41.
How much does it cost to publish in Therapeutic Advances in Hematology?
The publisher lists an article processing charge of about US$2,650 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Therapeutic Advances in Hematology and what is its ISSN?
Therapeutic Advances in Hematology is published by SAGE Publications Inc. Its print ISSN is 2040-6207 and its online ISSN is 2040-6215.
Is Therapeutic Advances in Hematology in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Therapeutic Advances in Hematology open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is Therapeutic Advances in Hematology? — open metrics via OpenAlex
Therapeutic Advances in Hematology has an h-index of 56 and a 2-year mean of 2.13 citations per paper (OpenAlex). Its Scopus CiteScore is 5.3, quartile Q1. On 2-year citations it ranks #43 of 148 Scopus journals in Hematology.
56
h-index
2.13
2-yr mean citations
351
i10-index
715
works indexed
13,795
total citations
Publication fee · open access list price, US$
US$2,650
2-yr mean citations, among Scopus journals in the same subject
#43 of 148 Top 30% Hematology
Therapeutic Advances in Hematology published 62 papers in 2025; its busiest recent year was 2021 with 65. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Therapeutic Advances in Hematology? — latest 99 articles, 2025–2026
In its latest 99 research articles (2025–2026), authors are most often from China (30.8%), United States (12.4%) and South Korea (5.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Therapeutic Advances in Hematology? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journals Journal Indexed in
Therapeutic Advances in Infectious Disease Scopus Q2 WoS ESCI DOAJ Therapeutic Advances in Medical Oncology Scopus Q1 WoS SCIE DOAJ Therapeutic Advances in Musculoskeletal Disease Scopus Q1 WoS SCIE DOAJ Therapeutic Advances in Psychopharmacology Scopus Q1 WoS SCIE DOAJ Therapeutic Advances in Urology Scopus Q1 WoS SCIE DOAJ Topics in Early Childhood Special Education Scopus Q1 WoS SSCI Toxicologic Pathology Scopus Q2 WoS SCIE Trends in Amplification Not in these indexes
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.